On June 12, 2025, Summit Therapeutics Inc. held its Annual Meeting where stockholders approved the election of nine directors, appointed PricewaterhouseCoopers LLP as auditors for 2025, and endorsed executive compensation. The decisions were made by requisite votes, with significant support for all proposals.